Screening for Chronic Kidney Disease (CKD) Among Older People Across Europe (SCOPE)
SCOPE
2 other identifiers
observational
2,434
7 countries
9
Brief Summary
The SCOPE study is an observational, multicenter, prospective cohort study aimed at evaluating a 2-year screening programme for CKD in a population of older patients, aged 75 years or more, in seven European Countries, in an attempt to investigate whether and to which extent currently available screening methods may identify older people at risk of worsening kidney function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2016
Typical duration for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2016
CompletedFirst Posted
Study publicly available on registry
February 25, 2016
CompletedStudy Start
First participant enrolled
August 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2020
CompletedJune 24, 2020
February 1, 2016
3.6 years
February 20, 2016
June 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Rate of estimated Glomerular Filtration Rate (eGFR) decline
eGFR will be calculated using the Berlin Initiative Study 1 (BIS1) equation
24 months
Incidence of End Stage Renal Disease (ESRD)
ESRD will be defined as eGFR\<15 mL/min/1.73 m2 or dialysis
24 months
Secondary Outcomes (7)
Biomarkers of kidney function
Baseline and 24 months
Genetic and epigenetic analyses
Baseline and 24 months
Incidence of CKD complications
24 months
Incidence of major comorbidities
24 months
Cardiovascular mortality
24 months
- +2 more secondary outcomes
Study Arms (1)
Subjects aged 75 years or older
Interventions
Eligibility Criteria
subjects with 75 years or older
You may qualify if:
- age≥75 years
- subjects attending the outpatient services at participating institutions
You may not qualify if:
- ESRD or dialysis
- history of solid organ or bone marrow transplantation
- active malignancy within 24 months prior to screening or metastatic cancer
- life expectancy less than 6 months
- severe cognitive impairment (MMSE\<10),
- any medical or other reason that the subject is unsuitable for the study
- subjects unwilling to provide consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istituto Nazionale di Ricovero e Cura per Anzianilead
- Ben-Gurion University of the Negevcollaborator
- Erasmus Medical Centercollaborator
- Medical University of Grazcollaborator
- Servicio Madrileño de Salud, Madrid, Spaincollaborator
- Institut Catala de Salutcollaborator
- UNIVERSYTET MEDYCZNY W LODZIcollaborator
- Friedrich-Alexander-Universität Erlangen-Nürnbergcollaborator
- Uppsala Universitycollaborator
Study Sites (9)
MEDIZINISCHE UNIVERSITAT- Internal Medicine/Nephrology/Geriatric Department
Graz, 8036, Austria
FRIEDRICH-ALEXANDER-UNIVERSITAT-Institute for Biomedicine of Aging
Erlangen, 91054, Germany
BEN-GURION UNIVERSITY-Geriatrics Department
Beersheba, 84105, Israel
INRCA Research Hospital
Ancona, 60131, Italy
INRCA Research Hospital
Cosenza, Italy
ERASMUS UNIVERSITAIR MEDISCH CENTRUM-Department of Internal Medicine
Rotterdam, 3015CE, Netherlands
UNIVERSYTET MEDYCZNY-Department of Geriatrics
Lodz, 90419, Poland
INSTITUT CATALA DE LA SALUT-Internal Medicine Deparment
Barcelona, 08007, Spain
SERVICIO MADRILENO DE SALUD-Geriatric Department
Madrid, 28020, Spain
Related Publications (6)
Freiberger E, Fabbietti P, Corsonello A, Lattanzio F, Sieber C, Tap L, Mattace-Raso F, Arnlov J, Carlsson AC, Roller-Wirnsberger R, Wirnsberger G, Moreno-Gonzalez R, Formiga F, Martinez SL, Gil P, Kostka T, Guligowska A, Yehoshua I, Melzer I, Kob R; SCOPE investigators. Short physical performance battery is not associated with falls and injurious falls in older persons: longitudinal data of the SCOPE project. Eur Geriatr Med. 2024 Jun;15(3):831-842. doi: 10.1007/s41999-024-00941-y. Epub 2024 Feb 28.
PMID: 38416398DERIVEDFreiberger E, Fabbietti P, Corsonello A, Lattanzio F, Artzi-Medvedik R, Kob R, Melzer I; SCOPE consortium; Britting S. Transient versus stable nature of fear of falling over 24 months in community-older persons with falls- data of the EU SCOPE project on Kidney function. BMC Geriatr. 2022 Aug 23;22(1):698. doi: 10.1186/s12877-022-03357-0.
PMID: 35999522DERIVEDTap L, Corsonello A, Formiga F, Moreno-Gonzalez R, Arnlov J, Carlsson AC, Roller-Wirnsberger R, Wirnsberger G, Ziere G, Freiberger E, Sieber C, Kostka T, Guligowska A, Gil P, Martinez SL, Artzi-Medvedik R, Yehoshua I, Fabbietti P, Lattanzio F, Mattace-Raso F; SCOPE investigators. Is kidney function associated with cognition and mood in late life? : The Screening for CKD among Older People across Europe (SCOPE) study. BMC Geriatr. 2020 Oct 2;20(Suppl 1):297. doi: 10.1186/s12877-020-01707-4.
PMID: 33008359DERIVEDBritting S, Artzi-Medvedik R, Fabbietti P, Tap L, Mattace-Raso F, Corsonello A, Lattanzio F, Arnlov J, Carlsson AC, Roller-Wirnsberger R, Wirnsberger G, Kostka T, Guligowska A, Formiga F, Moreno-Gonzalez R, Gil P, Martinez SL, Kob R, Melzer I, Freiberger E; SCOPE investigators. Kidney function and other factors and their association with falls : The screening for CKD among older people across Europe (SCOPE) study. BMC Geriatr. 2020 Oct 2;20(Suppl 1):320. doi: 10.1186/s12877-020-01698-2.
PMID: 33008307DERIVEDCorsonello A, Fabbietti P, Formiga F, Moreno-Gonzalez R, Tap L, Mattace-Raso F, Roller-Wirnsberger R, Wirnsberger G, Arnlov J, Carlsson AC, Weingart C, Freiberger E, Kostka T, Guligowska A, Gil P, Martinez SL, Melzer I, Yehoshua I, Lattanzio F; SCOPE investigators. Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance : The screening for CKD among older people across Europe (SCOPE) study. BMC Geriatr. 2020 Oct 2;20(Suppl 1):350. doi: 10.1186/s12877-020-01696-4.
PMID: 33008303DERIVEDCorsonello A, Tap L, Roller-Wirnsberger R, Wirnsberger G, Zoccali C, Kostka T, Guligowska A, Mattace-Raso F, Gil P, Fuentes LG, Meltzer I, Yehoshua I, Formiga-Perez F, Moreno-Gonzalez R, Weingart C, Freiberger E, Arnlov J, Carlsson AC, Bustacchini S, Lattanzio F; SCOPE investigators. Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study. BMC Nephrol. 2018 Oct 11;19(1):260. doi: 10.1186/s12882-018-1030-2.
PMID: 30309342DERIVED
Biospecimen
plasma, serum, whole blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2016
First Posted
February 25, 2016
Study Start
August 8, 2016
Primary Completion
March 10, 2020
Study Completion
March 10, 2020
Last Updated
June 24, 2020
Record last verified: 2016-02
Data Sharing
- IPD Sharing
- Will not share